EpiShuttle Approved in Australia!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
EpiGuard’s commitment to safety and quality was attested by our successful completion of an audit by the Norwegian Medicines Agency last June.
It’s been an exciting summer at EpiGuard, with the launch of our new e-Learning platform and the appointment of our new CEO, Michael Eimstad.
Be prepared for next Disease X! EpiShuttle e-learning will make patient isolation and transportation safer and more efficient!
Meet EpiGuard heroes – three brave men on the front line helping people of Ukraine.
Finland is investing in the future safety of their citizens by increasing national preparedness for pandemics and CBRNe events with EpiShuttles!
EpiGuard is proud to announce a new exclusive partnership with Leader Healthcare Group!